Guangxi LiuYao Group Co., Ltd (SHA:603368)
China · Delayed Price · Currency is CNY 18.10
-0.05 (-0.28%)
At close: Feb 6, 2026
Guangxi LiuYao Group Market Cap
Guangxi LiuYao Group has a market cap or net worth of 7.04 billion as of February 6, 2026. Its market cap has increased by 6.22% in one year.
Market Cap
7.04B
Enterprise Value
9.31B
Revenue
20.95B
Ranking
n/a
PE Ratio
9.15
Stock Price
18.10
Market Cap Chart
Since December 4, 2014, Guangxi LiuYao Group's market cap has increased from 4.25B to 7.04B, an increase of 65.79%. That is a compound annual growth rate of 4.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.04B | 1.58% |
| Dec 31, 2025 | 6.93B | -2.61% |
| Dec 31, 2024 | 7.12B | 4.58% |
| Dec 29, 2023 | 6.81B | 0.66% |
| Dec 30, 2022 | 6.76B | -1.81% |
| Dec 31, 2021 | 6.89B | -11.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Pharmaceuticals Holding | 57.78B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 39.78B |
| Jointown Pharmaceutical Group | 26.03B |
| China National Medicines Corporation | 22.05B |
| Liaoning Cheng Da | 18.31B |
| China Meheco Group | 16.13B |
| China National Accord Medicines Corporation | 13.72B |
| Qingdao Baheal Medical INC. | 12.60B |